Fuse is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace. We provide a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as, degenerative and deformity spine, osteobiologics, wound care, and regenerative products. For more information about the Company, or if you’re interested in becoming a distributor of any Fuse’s products, please contact us at info@fusemedical.com or visit: www.fusemedical.com.
Company profile
Ticker
FZMD
Exchange
Website
CEO
Christopher C. Reeg
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AMERICAN METALS SERVICE INC, GOLF ROUNDS COM INC
SEC CIK
Corporate docs
Subsidiaries
CPM Medical Consultants, LLC ...
IRS number
591224913
FZMD stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
27 Sep 23
8-K
Results of Operations and Financial Condition
27 Sep 23
8-K
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
15 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
26 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
DEFA14A
Additional proxy soliciting materials
10 May 23
DEF 14A
Definitive proxy
10 May 23
ARS
2022 FY
Annual report to shareholders
10 May 23
8-K
Results of Operations and Financial Condition
18 Apr 23
Latest ownership filings
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 253.38 k | 253.38 k | 253.38 k | 253.38 k | 253.38 k | |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 33.07 k | (no burn) | |
Cash used (since last report) | n/a | n/a | n/a | 297.03 k | n/a | |
Cash remaining | n/a | n/a | n/a | -43.65 k | n/a | |
Runway (months of cash) | n/a | n/a | n/a | -1.3 | n/a |
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Dec 22 | Reeg Christopher C | Grant | Acquire A | No | No | 0.15 | 333,333 | 50.00 k | 882,586 | |
15 Dec 22 | Brooks Mark W | Grant | Acquire A | No | No | 0.15 | 333,333 | 50.00 k | 882,586 | |
15 Dec 22 | Lawrence Scott Yellin | Grant | Acquire A | No | No | 0.15 | 333,333 | 50.00 k | 333,333 | |
16 Nov 22 | Brooks Mark W | Restricted Stock | Gift | Dispose G | Yes | No | 0 | 600,000 | 0.00 | 54,020,130 |